🔎 Trials Near Me

Akèy › Migrèn › Kalifòni

Etid klinik pou Migrèn nan Kalifòni

18 etid pou Migrèn ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

Study of EVO756 in Adults With Migraine

  • Buena Park Research Center, Buena Park
  • Neuro Pain Research Center, Fresno
  • CA Medical Clinic for Headache, Los Angeles
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT07616128

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  • Advanced Investigative Medicine, Inc., Hawthorne
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 28, 2026 · NCT05156398

MMA Embolization for Refractory Chronic Migraine

  • John Muir Physician Network Clin. Research Center, Walnut Creek
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT06735833

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Advanced Research Center, Inc., Anaheim
  • Neuro-Pain Research Center, Fresno
  • Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla
  • ak 4 plis
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Advanced Research Center, Inc., Anaheim
  • Adult & Child Neurology Medical Associates, Costa Mesa
  • Memorial Health Services, Fountain Valley
  • ak 9 plis
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  • Advanced Research Center /ID# 270257, Anaheim
  • Neuro Pain Research Center /ID# 271048, Fresno
  • Accellacare - Long Beach /ID# 270398, Long Beach
  • ak 3 plis
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

  • University of California San Francisco, San Francisco
Ap rekrite
Laj 10 a 17 · Tout sèks · Mizajou Sep 21, 2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Keck School of Medicine of USC, Los Angeles
  • Clinical Research Institute, Los Angeles
  • Desert Physicians Medical Group, Palm Springs
  • ak 1 plis
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Advanced Research Center /ID# 227962, Anaheim
  • Neuro Pain Research Center /ID# 227966, Fresno
  • Imax Clinical Trials /ID# 281436, La Palma
  • ak 7 plis
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Axiom Research, LLC, Colton
  • ProScience Research Group, Culver City
  • Leading Edge Research LA, LLC, Encino
  • ak 15 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924

Emgality for Migraine in Breastmilk

  • University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 a 45 · Fanm · Mizajou Aug 11, 2026 · NCT06085144

Treatment of Meniere's Disease With Migraine Medications

  • University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange
Ap rekriteFaz 4
Laj 25 a 85 · Tout sèks · Mizajou Jun 22, 2026 · NCT05582837

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

  • The Neurology Center of Southern California - Carlsbad Office, La Jolla
  • Clinical Research Institute, LCC, Los Angeles
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou May 19, 2026 · NCT06602479

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

  • Peter H Hwang, Stanford
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Apr 27, 2026 · NCT04930887

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

  • Neurology and Pain Specialty Center /ID# 278508, Aliso Viejo
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2026 · NCT07310290

Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics

  • Stanford University School of Medicine, Stanford
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2025 · NCT03231241

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

  • Upsher-Smith Clinical Trial Site #15, La Jolla
Ap rekriteFaz 4
Laj 6 a 11 · Tout sèks · Mizajou Jan 27, 2025 · NCT04748601

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.